Medicover
kr 254.00Change from previous close: −1.17%Absolute change: −kr 3.00
Valuation
Data as of October 4, 2026
Valuation multiples
- Market cap
- kr 38.6B
- Enterprise value
- kr 40.44B
- P/E (trailing 12 months)
- 40.0
- Forward P/E
- 552.2
- PEG
- 1.05
- Price/book
- 71.9
- Price/sales
- 15.6
- EV/EBITDA
- 144.8
- EV/revenue
- 16.4
Profitability and growth
- Gross margin
- 23.4%
- Operating margin
- 8.0%
- Net margin
- 3.4%
- ROE
- 15.5%
- ROA
- 4.7%
- ROIC
- 6.8%
- Revenue growth (year over year)
- 7.3%
- Earnings growth (year over year)
- 27.0%
Financial health
- Total cash
- kr 92.7M
- Total debt
- kr 1.46B
- Debt/equity
- 2.64
- Current ratio
- 0.55
- Quick ratio
- 0.48
- Altman Z-Score
- 2.15
- Piotroski F-Score
- 7.00
Dividends
- Annual dividend per share
- kr 2.18
- Dividend yield
- 0.9%
- Payout ratio
- 35.8%
- Ex-dividend date
- April 30, 2026
Analysts and estimates
- Average price target
- kr 268.09
- Median price target
- kr 257.37
- High price target
- kr 313.36
- Low price target
- kr 234.79
- Analysts with a price target
- 8
- Consensus
- Buy
- Forward EPS
- kr 0.46
- EPS estimate, current year
- kr 0.66
Shares and trading
- Beta
- 1.50
- Average volume
- 68.44K
- Shares outstanding
- 75.42M
- Float
- 53.13M
- Institutional ownership
- 45.6%
- Insider ownership
- 8.6%